résultats de votre recherche

Xingxing Zang - HHLA2 and TMIGD2: the newest members of the B7 and CD28 families

  • Date de parution : 12/05/2016
  • Durée : 28 min
  • Crédits :

Résumé de la vidéo

CTLA-4 and the PD-1/PD-L1 pathway are current focuses for cancer immunotherapy. This presentation will discuss other new immune checkpoints for human cancer immunotherapy, including HHLA2/TMIGD2, B7x, and B7-H3.

Thomas Gajewski - Targeting regulatory pathways in the tumor microenvironment for cancer immunotherapy

  • Date de parution : 12/05/2016
  • Durée : 34 min
  • Crédits :

Résumé de la vidéo

Dr. Thomas Gajewski carries out translational research with a focus on cancer immunology. He directs the Melanoma Oncology clinic, is Leader of the Immunology and Cancer Program, and oversees the Human Immunologic Monitoring (HIM)/cGMP Core Facility of the Comprehensive Cancer Center at the University of Chicago. His work focuses on understanding fundamental aspects of immune regulation, applying this knowledge towards studies of anti-tumor immunity, and c...

Affichage des vidéos




Vidéos les plus populaires